Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
The recommended PBS criteria are narrower than the general TGA prescribing criteria
44 : 604) Eur J Clin Pharmacol 1992
And the early data suggests that difference matters
Free consultation Benefits Triple mechanism of action only GLP-1 + GIP + glucagon agonist 40 mg in pen 4 full doses of 10 mg (up to 16 weeks with gradual escalation) 12 needles included + ALLUVI dosing instructions Isotonic solution, pH 6.57.5 comfortable injection Up to 24% weight loss over 48 weeks (Phase 2 study, NEJM 2023) Cold chain delivery with cooling elements (28C) across Ukraine Free 24/7 DOZA specialist support throughout the entire course Retatrutide 40 mg (ALLUVI) detailed description Retatrutide by ALLUVI Healthcare the world's first triple agonist targeting GLP-1, GIP and glucagon receptors in a convenient injection pen
Ginger (tea/candies), peppermint , or acupressure bands can help
Both Retatrutide and Sermorelin follow specific protocols designed to maximize benefits while minimizing side effects
